Clinical depression resident survival guide: Difference between revisions
Agnesrinky (talk | contribs) |
Agnesrinky (talk | contribs) |
||
(18 intermediate revisions by 4 users not shown) | |||
Line 19: | Line 19: | ||
{{WikiDoc CMG}}; {{AE}} {{RAB}} | {{WikiDoc CMG}}; {{AE}} {{RAB}} | ||
{{SK}} | {{SK}} Approach to depression, Approach to suicide, Suicide workup, Depression workup, Depression management | ||
==Overview== | ==Overview== | ||
[[Depression]] often leads to poor quality of life and impaired functioning.[[Clinical depression]] is defined as loss of [[Interest (emotion)|interest]] ([[anhedonia]]) and/or [[Depressed Mood|depressed]] mood for | [[Depression]] often leads to poor quality of life and impaired functioning. [[Clinical depression]] is defined as loss of [[Interest (emotion)|interest]] ([[anhedonia]]) and/or [[Depressed Mood|depressed]] mood for two or more weeks with at least 4 of the following features: [[sleep disturbances]], loss of [[appetite]]/increased [[appetite]], feeling guilty/worthless, loss of [[Energy|energy,]] loss of [[concentration]], [[psychomotor retardation]], or [[suicidal ideation]].The [[pathophysiology]] of [[depression]] is not completely understood, but it is thought that decreased levels of [[Neurotransmitter|monoaminergic neurotransmitter]]<nowiki/>s [[Dopamine]], [[Serotonin]] and [[Norepinephrine|Nor-epinephrine]] are responsible for depressed [[mood]]. When a patient with [[Depression|depressed]] [[mood]] comes to primary care, a detailed [[psychiatric]] interview is important to evaluate the [[psychiatric]] symptoms and assess the effect of symptoms on functioning of the patient. A physician is required to foster a positive rapport with the patient and help with sensitive matters. If needed, family and friends of the patient may be involved and [[Cultural psychology|cultura]]<nowiki/>l, [[Social Practice|social]], and situational factors should be considered to diagnose triggering factors. | ||
==Causes== | ==Causes== | ||
Line 47: | Line 47: | ||
*Medical conditions | *Medical conditions | ||
**[[Cardiovascular disease]]<ref name="pmid15581413">{{cite journal |vauthors=Manev R, Manev H |title=5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders |journal=Crit Rev Neurobiol |volume=16 |issue=1-2 |pages=181–6 |date=2004 |pmid=15581413 |doi=10.1615/critrevneurobiol.v16.i12.190 |url= |issn=}}</ref> | **[[Cardiovascular disease]]<ref name="pmid15581413">{{cite journal |vauthors=Manev R, Manev H |title=5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders |journal=Crit Rev Neurobiol |volume=16 |issue=1-2 |pages=181–6 |date=2004 |pmid=15581413 |doi=10.1615/critrevneurobiol.v16.i12.190 |url= |issn=}}</ref> | ||
**[[Hepatitis]]<ref name="pmid24644496">{{cite journal |vauthors=Alian S, Masoudzadeh A, Khoddad T, Dadashian A, Ali Mohammadpour R |title=Depression in hepatitis B and C, and its correlation with hepatitis drugs consumption (interfron/lamivodin/ribaverin) |journal=Iran J Psychiatry Behav Sci |volume=7 |issue=1 |pages=24–9 |date=2013 |pmid=24644496 |pmc=3939977 |doi= |url= |issn=}}</ref>:There is a high prevalence of [[depression]] in patients with [[hepatitis B]] and [[hepatitis C]] infection, especially those who are on [[Interferon]] [[therapy]]. | **[[Hepatitis]]<ref name="pmid24644496">{{cite journal |vauthors=Alian S, Masoudzadeh A, Khoddad T, Dadashian A, Ali Mohammadpour R |title=Depression in hepatitis B and C, and its correlation with hepatitis drugs consumption (interfron/lamivodin/ribaverin) |journal=Iran J Psychiatry Behav Sci |volume=7 |issue=1 |pages=24–9 |date=2013 |pmid=24644496 |pmc=3939977 |doi= |url= |issn=}}</ref>:<br>There is a high prevalence of [[depression]] in patients with [[hepatitis B]] and [[hepatitis C]] infection, especially those who are on [[Interferon]] [[therapy]]. | ||
**[[Mononucleosis]]<ref name="Senior1999">{{cite journal|last1=Senior|first1=Kathryn|title=Anecdotal link between mononucleosis and depression disproved|journal=The Lancet|volume=353|issue=9148|year=1999|pages=214|issn=01406736|doi=10.1016/S0140-6736(05)77225-1}}</ref><ref name="pmid3113655">{{cite journal |vauthors=White PD, Lewis SW |title=Delusional depression after infectious mononucleosis |journal=Br Med J (Clin Res Ed) |volume=295 |issue=6590 |pages=97–8 |date=July 1987 |pmid=3113655 |pmc=1246972 |doi=10.1136/bmj.295.6590.97-a |url= |issn=}}</ref> | **[[Mononucleosis]]<ref name="Senior1999">{{cite journal|last1=Senior|first1=Kathryn|title=Anecdotal link between mononucleosis and depression disproved|journal=The Lancet|volume=353|issue=9148|year=1999|pages=214|issn=01406736|doi=10.1016/S0140-6736(05)77225-1}}</ref><ref name="pmid3113655">{{cite journal |vauthors=White PD, Lewis SW |title=Delusional depression after infectious mononucleosis |journal=Br Med J (Clin Res Ed) |volume=295 |issue=6590 |pages=97–8 |date=July 1987 |pmid=3113655 |pmc=1246972 |doi=10.1136/bmj.295.6590.97-a |url= |issn=}}</ref> | ||
**[[Hypothyroidism]]<ref name="pmid24847450">{{cite journal |vauthors=Dayan CM, Panicker V |title=Hypothyroidism and depression |journal=Eur Thyroid J |volume=2 |issue=3 |pages=168–79 |date=September 2013 |pmid=24847450 |pmc=4017747 |doi=10.1159/000353777 |url= |issn=}}</ref> | **[[Hypothyroidism]]<ref name="pmid24847450">{{cite journal |vauthors=Dayan CM, Panicker V |title=Hypothyroidism and depression |journal=Eur Thyroid J |volume=2 |issue=3 |pages=168–79 |date=September 2013 |pmid=24847450 |pmc=4017747 |doi=10.1159/000353777 |url= |issn=}}</ref> | ||
Line 64: | Line 64: | ||
*Dietary | *Dietary | ||
**[[Alcohol]] | **[[Alcohol]] | ||
**Poor [[Diet (nutrition)|diet]]: Deficiency of [[Vitamin| | **Poor [[Diet (nutrition)|diet]]:<br>Deficiency of [[Vitamin|vitamins]], [[Mineral|minerals]], and [[Omega-3 fatty acids|omega-3 fatty aci]]<nowiki/>[[Omega-3 fatty acids|d]]<nowiki/>s<ref name="pmid19742217">{{cite journal |vauthors=Rao TS, Asha MR, Ramesh BN, Rao KS |title=Understanding nutrition, depression and mental illnesses |journal=Indian J Psychiatry |volume=50 |issue=2 |pages=77–82 |date=April 2008 |pmid=19742217 |pmc=2738337 |doi=10.4103/0019-5545.42391 |url= |issn=}}</ref> | ||
*[[Seasonal affective disorder|Seasonal Affective Disorder]]: Due to production of excessive [[melatonin]] | *[[Seasonal affective disorder|Seasonal Affective Disorder]]: | ||
*Due to production of excessive [[melatonin]] | |||
*[[Postpartum Depression]] | *[[Postpartum Depression]] | ||
*Drugs:<ref name="pmid28216784">{{cite journal |vauthors=Gautam S, Jain A, Gautam M, Vahia VN, Grover S |title=Clinical Practice Guidelines for the management of Depression |journal=Indian J Psychiatry |volume=59 |issue=Suppl 1 |pages=S34–S50 |date=January 2017 |pmid=28216784 |pmc=5310101 |doi=10.4103/0019-5545.196973 |url= |issn=}}</ref> | *Drugs:<ref name="pmid28216784">{{cite journal |vauthors=Gautam S, Jain A, Gautam M, Vahia VN, Grover S |title=Clinical Practice Guidelines for the management of Depression |journal=Indian J Psychiatry |volume=59 |issue=Suppl 1 |pages=S34–S50 |date=January 2017 |pmid=28216784 |pmc=5310101 |doi=10.4103/0019-5545.196973 |url= |issn=}}</ref> | ||
**[[Cardiovascular]] drugs:[[ACE inhibitor|ACEI]],[[Calcium channel blocker|Calcium Channel blockers]],[[Digitalis]],[[Clonidine]], [[Hydralazine]],[[Methyldopa|Methyl-dopa]], [[Procainamide]],[[Propranolol|Propanolol]],[[Thiazide]] and [[Diuretic|Zolamide diuretics]], [[Reserpine]] | **[[Cardiovascular]] drugs:<br>[[ACE inhibitor|ACEI]],[[Calcium channel blocker|Calcium Channel blockers]],[[Digitalis]],[[Clonidine]], [[Hydralazine]],[[Methyldopa|Methyl-dopa]], [[Procainamide]],[[Propranolol|Propanolol]],[[Thiazide]] and [[Diuretic|Zolamide diuretics]], [[Reserpine]] | ||
**[[Antiparkinsonian|Anti-parkinsonian]] drugs: [[Levodopa]], [[Amantadine]], [[Bromocriptine]] | **[[Antiparkinsonian|Anti-parkinsonian]] drugs: <br>[[Levodopa]], [[Amantadine]], [[Bromocriptine]] | ||
**[[Anticonvulsants|Anti-convulsants]]:[[Ethosuximide]], [[Phenobarbital]], [[Phenytoin]],[[Vigabatrin]],[[Tiagabine]] | **[[Anticonvulsants|Anti-convulsants]]:<br>[[Ethosuximide]], [[Phenobarbital]], [[Phenytoin]],[[Vigabatrin]],[[Tiagabine]] | ||
**[[Anti-psychotic]]: [[Fluphenazine]],[[Haloperidol]] | **[[Anti-psychotic]]: <br>[[Fluphenazine]],[[Haloperidol]] | ||
**[[Chemotherapeutics]]:[[Azathioprine]], [[Bleomycin]], [[Cisplatin]],[[Cyclophosphamide]], [[Vinblastine]], [[Vincristine]] | **[[Chemotherapeutics]]:<br>[[Azathioprine]], [[Bleomycin]], [[Cisplatin]],[[Cyclophosphamide]], [[Vinblastine]], [[Vincristine]] | ||
**[[Stimulants]]: [[Amphetamine]] [[Withdrawal syndrome|withdrawal]], [[Cocaine]] [[Withdrawal syndrome|withdrawal]] | **[[Stimulants]]: <br>[[Amphetamine]] [[Withdrawal syndrome|withdrawal]], [[Cocaine]] [[Withdrawal syndrome|withdrawal]] | ||
**[[AIDS antiretroviral drugs|Anti-retroviral]]:[[Atazanavir]][[Efavirenz|,Efavirenz]], [[Zidovudine]], [[Saquinavir]] | **[[AIDS antiretroviral drugs|Anti-retroviral]]:<br>[[Atazanavir]][[Efavirenz|,Efavirenz]], [[Zidovudine]], [[Saquinavir]] | ||
**[[Sedative]] and [[anxiolytics]]: [[Barbiturate|Barbiturates]], [[Ethanol]], [[Benzodiazepine|Benzodiazepines]] | **[[Sedative]] and [[anxiolytics]]: <br>[[Barbiturate|Barbiturates]], [[Ethanol]], [[Benzodiazepine|Benzodiazepines]] | ||
==Diagnosis== | ==Diagnosis== | ||
Shown below is an algorithm summarizing the diagnosis of [[Clinical depression|Clinical Depression]]<ref name="pmid28216784">{{cite journal |vauthors=Gautam S, Jain A, Gautam M, Vahia VN, Grover S |title=Clinical Practice Guidelines for the management of Depression |journal=Indian J Psychiatry |volume=59 |issue=Suppl 1 |pages=S34–S50 |date=January 2017 |pmid=28216784 |pmc=5310101 |doi=10.4103/0019-5545.196973 |url= |issn=}}</ref><ref name="pmid11556941">{{cite journal |vauthors=Kroenke K, Spitzer RL, Williams JB |title=The PHQ-9: validity of a brief depression severity measure |journal=J Gen Intern Med |volume=16 |issue=9 |pages=606–13 |date=September 2001 |pmid=11556941 |pmc=1495268 |doi=10.1046/j.1525-1497.2001.016009606.x |url= |issn=}}</ref><ref name="urlThe Mental Status Examination - Clinical Methods - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK320/ |title=The Mental Status Examination - Clinical Methods - NCBI Bookshelf |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | Shown below is an algorithm summarizing the diagnosis of [[Clinical depression|Clinical Depression]]<ref name="pmid28216784">{{cite journal |vauthors=Gautam S, Jain A, Gautam M, Vahia VN, Grover S |title=Clinical Practice Guidelines for the management of Depression |journal=Indian J Psychiatry |volume=59 |issue=Suppl 1 |pages=S34–S50 |date=January 2017 |pmid=28216784 |pmc=5310101 |doi=10.4103/0019-5545.196973 |url= |issn=}}</ref><ref name="pmid11556941">{{cite journal |vauthors=Kroenke K, Spitzer RL, Williams JB |title=The PHQ-9: validity of a brief depression severity measure |journal=J Gen Intern Med |volume=16 |issue=9 |pages=606–13 |date=September 2001 |pmid=11556941 |pmc=1495268 |doi=10.1046/j.1525-1497.2001.016009606.x |url= |issn=}}</ref><ref name="urlThe Mental Status Examination - Clinical Methods - NCBI Bookshelf">{{cite web |url=https://www.ncbi.nlm.nih.gov/books/NBK320/ |title=The Mental Status Examination - Clinical Methods - NCBI Bookshelf |author= |authorlink= |coauthors= |date= |format= |work= |publisher= |pages= |language= |archiveurl= |archivedate= |quote= |accessdate=}}</ref> | ||
{{Family tree/start}} | {{Family tree/start}} | ||
{{Family tree | | | | | | | A01 | | | |A01=Patient with | {{Family tree | | | | | | | A01 | | | |A01=Patient with clinical [[depression]]}} | ||
{{Family tree | | | | | | | |!| | | | | }} | {{Family tree | | | | | | | |!| | | | | }} | ||
{{Family tree | | | | | | | B01 | | | |B01= Take complete history}} | {{Family tree | | | | | | | B01 | | | |B01= Take complete history}} | ||
Line 123: | Line 124: | ||
❑ '''Level of [[consciousness]]:<br>''' See if patient reacts to stimuli<br><br> ❑ '''Appearance and general behavior''':<br> | ❑ '''Level of [[consciousness]]:<br>''' See if patient reacts to stimuli<br><br> ❑ '''Appearance and general behavior''':<br> | ||
Look for patient's physical appearance, grooming (clean/untidy or dishevelled appearance), dress (subdued/riotous), posture ([[erect]]/[[Kyphosis|kyphotic]]) <br><br> ❑'''[[Speech]] and motor activity:<br> | Look for patient's physical appearance, grooming (clean/untidy or dishevelled appearance), dress (subdued/riotous), posture ([[erect]]/[[Kyphosis|kyphotic]]) <br><br> ❑'''[[Speech]] and motor activity:<br> | ||
Ask them open-ended questions and check if there is any word-finding difficulties, or the rapid and pressured [[speech]], [[tics]] or unusual mannerisms,look for slowness and loss of spontaneity in movement,look for [[akathisia]] or motor restlessness <br><br> ❑ '''[[Affect]] and [[mood]]''':<br> | |||
Look for restricted, labile, or [[flat affect]] <br><br> ❑ '''Thought and Perception''':<br> | Look for restricted, labile, or [[flat affect]] <br><br> ❑ '''Thought and Perception''':<br> | ||
Evaluate how the patient perceives and responds to stimuli. <br> | Evaluate how the patient perceives and responds to stimuli. <br> | ||
Line 180: | Line 181: | ||
{{Family tree | | | | | | | B01 | | | |B01= Determine the level of severity and functional impairment||}} | {{Family tree | | | | | | | B01 | | | |B01= Determine the level of severity and functional impairment||}} | ||
{{Family tree | | | | | | | |!| | | | | }} | {{Family tree | | | | | | | |!| | | | | }} | ||
{{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | B02 | | | |B02=<div style="float: left; text-align: left; height: 25em; width: 25em; padding:1em;"> '''Is referral to mental health care indicated?:'''<br> | ||
---- | ---- | ||
❑ Unclear diagnosis <br><br>❑ Evidence of psychotic features, [[mania]], [[Hypomania|hypomania]] <br><br>❑ Signs of co-morbid [[psychiatric]] conditions<br><br> | ❑ Unclear diagnosis <br><br>❑ Evidence of psychotic features, [[mania]], [[Hypomania|hypomania]] <br><br>❑ Signs of co-morbid [[psychiatric]] conditions<br><br> | ||
Line 198: | Line 199: | ||
<table class="wikitable"> | <table class="wikitable"> | ||
<tr class="v-firstrow"><th>'''Severity '''</th><th>'''PHQ-9 Score'''</th><th>'''Functional impairment'''</th><th>'''Initial treatment'''</th></tr> | <tr class="v-firstrow"><th>'''Severity '''</th><th>'''PHQ-9 Score'''</th><th>'''Functional impairment'''</th><th>'''Initial treatment'''</th></tr> | ||
<tr><td>Mild</td><td>10-14</td><td>Mild</td><td>'''[[Monotherapy]]-[[ | <tr><td>Mild</td><td>10-14</td><td>Mild</td><td>'''[[Monotherapy]]-[[antidepressant]] or [[psychotherapy]]; or possibly combination of both'''</td></tr> | ||
<tr><td>Moderate</td><td>15-19</td><td>Moderate</td><td>'''[[Antidepressant]] or [[psychotherapy]]; or possibly combination of both'''</td></tr> | <tr><td>Moderate</td><td>15-19</td><td>Moderate</td><td>'''[[Antidepressant]] or [[psychotherapy]]; or possibly combination of both'''</td></tr> | ||
<tr><td>Severe</td><td>>/=20</td><td>Severe</td><td>'''May start with [[ | <tr><td>Severe</td><td>>/=20</td><td>Severe</td><td>'''May start with [[antidepressant]] or [[psychotherapy]] but prefer combination of both'''</td></tr> | ||
</table>}} | </table>}} | ||
{{Family tree | | | |!| | | | | }} | {{Family tree | | | |!| | | | | }} | ||
{{Family tree | | | B01 |-|-|-|.| |B01=<div style="float: left; text-align: left; height: | {{Family tree | | | B01 |-|-|-|.| |B01=<div style="float: left; text-align: left; height: 25em; width: 10em; padding:1em;"> '''Follow up in 2 weeks:'''<br> | ||
---- | ---- | ||
❑ Symptoms improved <br><br>❑ Treatment is well-tolerated and no side-effects<br><br>❑ Patient is adhering to treatment<br><br> | ❑ Symptoms improved <br><br>❑ Treatment is well-tolerated and no side-effects<br><br>❑ Patient is adhering to treatment<br><br> | ||
</div> |}} | </div> |}} | ||
{{Family tree | | | | |!| | | |!| }} | {{Family tree | | | | |!| | | |!| }} | ||
{{Family tree | | | | A01 | | |)|-|p09|-|n09| | n09=<div style="float: left; text-align: left; height: | {{Family tree | | | | A01 | | |)|-|p09|-|n09| | n09=<div style="float: left; text-align: left; height: 30em; width: 10em; padding:1em;"> '''Modify treatment:'''<br> | ||
---- | ---- | ||
❑ Increase [[dose]] <br>❑ Augmentation of the [[medication]] <br><br>❑ Switch to another agent<br><br>❑ Combine [[psychotherapy]] and [[pharmacotherapy]]<br><br>❑ Somatic intervention<br><br>❑ Inpatient/residential treatment | ❑ Increase [[dose]] <br>❑ Augmentation of the [[medication]] <br><br>❑ Switch to another agent<br><br>❑ Combine [[psychotherapy]] and [[pharmacotherapy]]<br><br>❑ Somatic intervention<br><br>❑ Inpatient/residential treatment | ||
Line 217: | Line 218: | ||
❑ Presence of [[suicidal]] ideation <br><br>❑ Refusal to eat or drink <br><br>❑ Severe [[malnutrition]]<br><br>❑ Presence of [[Psychiatric|psychiatric]] conditions or other general medical comorbidity that make outpatient [[treatment]] unsafe or ineffective<br> | ❑ Presence of [[suicidal]] ideation <br><br>❑ Refusal to eat or drink <br><br>❑ Severe [[malnutrition]]<br><br>❑ Presence of [[Psychiatric|psychiatric]] conditions or other general medical comorbidity that make outpatient [[treatment]] unsafe or ineffective<br> | ||
<br>❑ [[Catatonia]]<br><br> | <br>❑ [[Catatonia]]<br><br> | ||
</div> |B01=❑ Continue current [[treatment]]<br> | </div> |B01=❑ Continue current [[treatment]]<br><br> | ||
❑Re-assess in 4-6 weeks||}} | ❑Re-assess in 4-6 weeks||}} | ||
{{Family tree | | | | |!| | | |!| | | | | }} | {{Family tree | | | | |!| | | |!| | | | | }} | ||
Line 244: | Line 245: | ||
{{Family tree | | |!| | | |!| |!| | | | | | |!| |!| | |}} | {{Family tree | | |!| | | |!| |!| | | | | | |!| |!| | |}} | ||
{{Family tree | | |!| | | |!| |!| | | | | | |!| |!| | | }} | {{Family tree | | |!| | | |!| |!| | | | | | |!| |!| | | }} | ||
{{Family tree | | |!| |t09|-|p09 |-|-|-|-|^|-|r07 |r07=Change to [[ | {{Family tree | | |!| |t09|-|p09 |-|-|-|-|^|-|r07 |r07=Change to [[anti-depressant]]<br> OR <br>Switch to [[psychotherapy]]|t09=Change to [[anti-depressant]]|p09=Partial Response }} | ||
{{Family tree | | |!| | | | | | |!| | | | | }} | {{Family tree | | |!| | | | | | |!| | | | | }} | ||
{{Family tree | | |!| | | | | | |!| | | | | }} | {{Family tree | | |!| | | | | | |!| | | | | }} | ||
{{Family tree | | |)|-|-|-|-| b09 | | | | | | | |b09=<div style="float: left; text-align: left; height: 15em; width: 15em; padding:1em;"> '''Optimize the [[treatment]]:'''<br> | {{Family tree | | |)|-|-|-|-| b09 | | | | | | | |b09=<div style="float: left; text-align: left; height: 15em; width: 15em; padding:1em;"> '''Optimize the [[treatment]]:'''<br> | ||
---- | ---- | ||
❑ Increase frequency of [[psychotherapy]]<br><br> | ❑ Increase frequency of [[psychotherapy]]<br><br>❑ Give maximum tolerable doses of the [[antidepressant|anti depressant]]<br><br> | ||
</div> |}} | </div> |}} | ||
{{Family tree | | |!| | | | | | |!| | | | | }} | {{Family tree | | |!| | | | | | |!| | | | | }} | ||
{{Family tree | | |!| | | | | | |!| | | | | }} | {{Family tree | | |!| | | | | | |!| | | | | }} | ||
{{Family tree | | |!| | | | | b09 | | | | | | | |b09=<div style="float: left; text-align: left; height: | {{Family tree | | |!| | | | | b09 | | | | | | | |b09=<div style="float: left; text-align: left; height: 20em; width: 15em; padding:1em;"> '''Change or give combination therapy:'''<br> | ||
---- | ---- | ||
❑ If patient is getting [[psychotherapy]]: Add [[antidepressant]]<br><br> | ❑ If patient is getting [[psychotherapy]]: Add [[antidepressant]]<br><br>❑ If patient is recieving [[Antidepressant|antidepressant]]:<br>Add [[psychotherapy]] or change the [[Antidepressant|anti depressant]]<br><br> | ||
</div> |}} | </div> |}} | ||
{{Family tree | | |!| | | | | | |!| | | | | }} | {{Family tree | | |!| | | | | | |!| | | | | }} | ||
Line 261: | Line 262: | ||
{{Family tree | | |`|-|-|-|-| b09 | | | | | | | |b09=<div style="float: left; text-align: left; height: 15em; width: 15em; padding:1em;"> '''Augmentation/Combination:'''<br> | {{Family tree | | |`|-|-|-|-| b09 | | | | | | | |b09=<div style="float: left; text-align: left; height: 15em; width: 15em; padding:1em;"> '''Augmentation/Combination:'''<br> | ||
---- | ---- | ||
❑ If patient is recieving [[antidepressant]]:<br>Add a second [[Antidepressant|antidepressant]] OR augment the medication depending on tolerability and side effects<br><br> | ❑ If patient is recieving [[antidepressant]]:<br>Add a second [[Antidepressant|antidepressant]] <br>OR<br> augment the medication depending on tolerability and side effects<br><br> | ||
</div> |}} | </div> |}} | ||
{{familytree/end}} | {{familytree/end}} | ||
Line 275: | Line 276: | ||
{{Family tree | | | | |,|-|-|^|-|-|-|-|-|-|-|.| | }} | {{Family tree | | | | |,|-|-|^|-|-|-|-|-|-|-|.| | }} | ||
{{Family tree | | | | |!| | | | | | | | | | |!| | }} | {{Family tree | | | | |!| | | | | | | | | | |!| | }} | ||
{{Family tree | | | | |p09| | | | | | | | |y09| |y09=<div style="float: left; text-align: left; height: | {{Family tree | | | | |p09| | | | | | | | |y09| |y09=<div style="float: left; text-align: left; height: 40em; width: 15em; padding:1em;"> '''Assess the patient:'''<br> | ||
---- | ---- | ||
❑ Ask about patient's preference of [[treatment]]<br><br>❑ Past history or family history of good response to treatment of [[ECT]]<br><br>❑ Low risk of [[drug]] interaction<br><br>❑ High risk of [[suicide]]<br><br> | |||
</div> |p09=<div style="float: left; text-align: left; height: 25em; width: 15em; padding:1em;"> '''Assess the patient:'''<br> | </div> |p09=<div style="float: left; text-align: left; height: 25em; width: 15em; padding:1em;"> '''Assess the patient:'''<br> | ||
---- | ---- | ||
Line 287: | Line 288: | ||
{{Family tree | | | | |`|-|-|-|-|-|-|-|-|-|-|p09| |y09| |y09=Partial response |p09=No response }} | {{Family tree | | | | |`|-|-|-|-|-|-|-|-|-|-|p09| |y09| |y09=Partial response |p09=No response }} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | |!|}} | {{Family tree | | | | | | | | | | | | | | | | | | | | |!|}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | |b09 | | | | | | | |b09=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | | | | | | | | | | | | | | |b09 | | | | | | | |b09=<div style="float: left; text-align: left; height: 10em; width: 15em; padding:1em;"> '''Optimize the [[treatment]]:'''<br> | ||
---- | ---- | ||
❑ Give the maximum tolerable doses of the [[antidepressant]]<br> | ❑ Give the maximum tolerable doses of the [[antidepressant]]<br> | ||
Line 293: | Line 294: | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | |!|}} | {{Family tree | | | | | | | | | | | | | | | | | | | | |!|}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | |!|}} | {{Family tree | | | | | | | | | | | | | | | | | | | | |!|}} | ||
{{Family tree | | | | | | | | | | | | | | | | | | | | |p09| | p09=<div style="float: left; text-align: left; height: | {{Family tree | | | | | | | | | | | | | | | | | | | | |p09| | p09=<div style="float: left; text-align: left; height: 25em; width: 15em; padding:1em;"> '''No further response:'''<br> | ||
---- | ---- | ||
❑ Switch to a different [[antidepressant]] from same or different [[pharmalogical]] class<br><br>❑ Add [[ECT]]<br><br>❑ Add a second [[Antidepressant|anti depressant]]<br><br>❑ Augment the [[medication]]<br> | ❑ Switch to a different [[antidepressant]] from same or different [[pharmalogical]] class<br><br>❑ Add [[ECT]]<br><br>❑ Add a second [[Antidepressant|anti depressant]]<br><br>❑ Augment the [[medication]]<br> | ||
Line 312: | Line 313: | ||
*[[Paroxetine]] | *[[Paroxetine]] | ||
*[[Fluvoxamine]] | *[[Fluvoxamine]] | ||
*[[ | *[[Sertraline]] | ||
*[[Citalopram]] | *[[Citalopram]] | ||
*[[Escitalopram]] | *[[Escitalopram]] | ||
Line 365: | Line 366: | ||
*[[Trazodone]]<br> | *[[Trazodone]]<br> | ||
*[[Nefazodone]] | *[[Nefazodone]] | ||
|<br>150-300<br>100-300 | |<br>150-300<br>100-300 | ||
| | | | ||
Line 399: | Line 400: | ||
==Do's== | ==Do's== | ||
*If the patient has any [[suicidal ideation]], the physician should ask | *If the [[patient]] has any [[suicidal ideation]], the physician should ask if he/she has any plan to execute it or if he/she has any previous attempts. If they have any specific plan, admit the [[patient]]. | ||
*If any patient tells they want to hurt someone, the physician should inform that person as well as to police authority. | *If any [[patient]] tells they want to hurt someone, the physician should inform that person as well as to police authority. | ||
*Be empathetic to the patient and listen to them. | *Be empathetic to the [[patient]] and listen to them. | ||
*Motivate them to continue the [[treatment]] | *Motivate them to continue the [[treatment]] long term and help them with [[medication]] adherence. | ||
==Don'ts== | ==Don'ts== | ||
*Do not let the patient stay alone and do not keep firearms if they are [[suicidal]]. | *Do not let the [[patient]] stay alone and do not keep firearms if they are [[suicidal]]. | ||
==References== | ==References== | ||
Line 418: | Line 419: | ||
[[Category:Resident survival guide]] | [[Category:Resident survival guide]] | ||
[[Category:Psychiatry]] | [[Category:Psychiatry]] | ||
[[Category:Needs English review]] | |||
Latest revision as of 10:07, 13 March 2021
Clinical depression Resident Survival Guide Microchapters |
---|
Overview |
Causes |
Diagnosis |
Treatment |
Do's |
Don'ts |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rinky Agnes Botleroo, M.B.B.S.
Synonyms and keywords: Approach to depression, Approach to suicide, Suicide workup, Depression workup, Depression management
Overview
Depression often leads to poor quality of life and impaired functioning. Clinical depression is defined as loss of interest (anhedonia) and/or depressed mood for two or more weeks with at least 4 of the following features: sleep disturbances, loss of appetite/increased appetite, feeling guilty/worthless, loss of energy, loss of concentration, psychomotor retardation, or suicidal ideation.The pathophysiology of depression is not completely understood, but it is thought that decreased levels of monoaminergic neurotransmitters Dopamine, Serotonin and Nor-epinephrine are responsible for depressed mood. When a patient with depressed mood comes to primary care, a detailed psychiatric interview is important to evaluate the psychiatric symptoms and assess the effect of symptoms on functioning of the patient. A physician is required to foster a positive rapport with the patient and help with sensitive matters. If needed, family and friends of the patient may be involved and cultural, social, and situational factors should be considered to diagnose triggering factors.
Causes
Life Threatening Causes
Life-threatening causes include conditions includes:
Common Causes
- Genetic predisposition
- Life experiences
- Divorce or the end of a serious relationship
- Eating disorders
- Financial difficulties or poverty
- Gambling addiction
- Grief over the death of a child, spouse, other family members, or friends.
- Job loss or unemployment
- Loss of religious faith[1]
- Ongoing major health problems
- Medical conditions
- Cardiovascular disease[2]
- Hepatitis[3]:
There is a high prevalence of depression in patients with hepatitis B and hepatitis C infection, especially those who are on Interferon therapy. - Mononucleosis[4][5]
- Hypothyroidism[6]
- Sleep apnea[7]
- Fructose malabsorption[8]
- Parkinson disease[9]
- Multiple Sclerosis [10]
- Hormonal contraception[11]
- Steroids
- Addison's disease[12]
- Syphilis
- Post- stroke[13]
- Thyrotoxicosis
- Diabetes Mellitus
- Attention-Deficit/Hyperactivity Disorder (ADHD)[14]
- Dietary
- Seasonal Affective Disorder:
- Due to production of excessive melatonin
- Postpartum Depression
- Drugs:[16]
- Cardiovascular drugs:
ACEI,Calcium Channel blockers,Digitalis,Clonidine, Hydralazine,Methyl-dopa, Procainamide,Propanolol,Thiazide and Zolamide diuretics, Reserpine - Anti-parkinsonian drugs:
Levodopa, Amantadine, Bromocriptine - Anti-convulsants:
Ethosuximide, Phenobarbital, Phenytoin,Vigabatrin,Tiagabine - Anti-psychotic:
Fluphenazine,Haloperidol - Chemotherapeutics:
Azathioprine, Bleomycin, Cisplatin,Cyclophosphamide, Vinblastine, Vincristine - Stimulants:
Amphetamine withdrawal, Cocaine withdrawal - Anti-retroviral:
Atazanavir,Efavirenz, Zidovudine, Saquinavir - Sedative and anxiolytics:
Barbiturates, Ethanol, Benzodiazepines
- Cardiovascular drugs:
Diagnosis
Shown below is an algorithm summarizing the diagnosis of Clinical Depression[16][17][18]
Patient with clinical depression | |||||||||||||||||||||||||
Take complete history | |||||||||||||||||||||||||
Do initial screening | |||||||||||||||||||||||||
Yes | No | ||||||||||||||||||||||||||||||||||
Repeat screening annually | |||||||||||||||||||||||||||||||||||
Ask the following questions about last 2 weeks: ❑ Do you feel low/ hopeless or sad? ❑ Is there any trouble falling or staying asleep, or sleeping too much ❑ Do you feel guilty about anything?Do you feel bad about yourself—or that you are a failure or have let yourself or your family down ❑ Do you feel tired/ fatigued most of the time of the day? ❑ Can you concentrate on usual work? Are you having trouble concentrating on things, such as reading the newspaper or watching television ❑ Have you noticed any changes in appetite? ❑ Have you been moving or speaking so slowly that other people could have noticed? Or the opposite—being so fidgety or restless that you have been moving around a lot more than usual ❑ Have you had any thoughts of death and/or suicide, suicide planning, or a suicide attempt | |||||||||||||||||||||||||
General Physical Examination: ❑ Look for thyroid swelling ❑ Look for symptoms of malnutrition and specific nutritional deficiency | |||||||||||||||||||||||||
Perform mental status examination: ❑ Level of consciousness: | |||||||||||||||||||||||||
Establish a diagnosis | |||||||||||||||||||||||||
Differential diagnosis by ruling out secondary depression | |||||||||||||||||||||||||
Rule out bipolar disorder, premenstrual dysphoric disorder | |||||||||||||||||||||||||
Assessment: ❑ Assess the severity of the disease ❑ Assess their level of functioning: Ask if there is any work dysfunction ❑ Do detailed physical examination to rule out any disease that can contribute to depression | |||||||||||||||||||||||||
Do basic investigations: ❑ Haemoglobin ❑ Blood sugar ❑ Lipid levels ❑ Liver function test ❑ Renal function test ❑ Thyroid function test ❑ Urine pregnancy test(If required) | |||||||||||||||||||||||||
Ask about previous treatment history: ❑ Ask if they have any past medical illness ❑ Ask if they take any medications ❑ Ask about response to any prior treatment of depression (if they recieved any treatment earlier) | |||||||||||||||||||||||||
Treatment
Shown below is an algorithm summarizing the treatment of Clinical depression:
Abbreviations: ECT: Electroconvulsive Therapy,MAOI= Monoamine oxidase Inhibitor, TCA= Tricyclic Antidepressant,SSRI= Selective Serotonin Reuptake Inhibitor
Presumptive diagnosis of Clinical Depression | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Determine the level of severity and functional impairment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Is referral to mental health care indicated?: ❑ Unclear diagnosis ❑ Need for psychosocial interventions ❑ Patient preference | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Discuss treatment options and patient's preferences | Refer to mental health specialty care | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Initiate treatment according to severity and follow-up in 1-2 weeks
| |||||||||||||||||||||||||||||||||||||
Follow up in 2 weeks: ❑ Symptoms improved | |||||||||||||||||||||||||||||||||||||
Yes | No | Modify treatment: ❑ Increase dose | |||||||||||||||||||||||||||||||||||
❑ Continue current treatment ❑Re-assess in 4-6 weeks | Some indications for inpatient care: ❑ Presence of suicidal ideation | ||||||||||||||||||||||||||||||||||||
Yes | |||||||||||||||||||||||||||||||||||||
Mild to Moderate Depression
The algorithm below shows the management plan in brief in case of mild, moderate, and severe depression:
Mild to moderate Depression | |||||||||||||||||||||||||||||||||||||||||||||
Remission | Psychotherapy | Pharmacotherapy | Remission | ||||||||||||||||||||||||||||||||||||||||||
No response | No response | ||||||||||||||||||||||||||||||||||||||||||||
Change to anti-depressant | Partial Response | Change to anti-depressant OR Switch to psychotherapy | |||||||||||||||||||||||||||||||||||||||||||
Optimize the treatment: ❑ Increase frequency of psychotherapy | |||||||||||||||||||||||||||||||||||||||||||||
Change or give combination therapy: ❑ If patient is getting psychotherapy: Add antidepressant | |||||||||||||||||||||||||||||||||||||||||||||
Augmentation/Combination: ❑ If patient is recieving antidepressant: | |||||||||||||||||||||||||||||||||||||||||||||
Severe Depression
The algorithm below shows the management plan in brief in case of severe depression:
Severe Depression | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Assess the patient: ❑ Ask about patient's preference of treatment | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ECT+Pharmacotherapy | Pharmacotherapy | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No response | Partial response | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
No further response: ❑ Switch to a different antidepressant from same or different pharmalogical class | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medications
Medications used to treat Depression:[16]
Mechanism | Name | Dose | Side effects |
---|---|---|---|
Selective Serotonin Reuptake Inhibitor | 20-80 20-60 50-300 50-200 20-40 10-20 |
||
Tricyclic antidepressant | 50-200 75-300 75-300 75-300 |
| |
Norepinephrine Serotonin Reuptake Inhibitor | 75-300 20-60 50-200 |
| |
Non adrenaline and Specific Serotonin Inhibitor | 15-45 |
| |
Atypical antidepressant | 150-300 100-300 |
| |
Mono amine oxidase Inhibitors | 45-90 30-60 20-60 |
||
Selective Serotonin Reuptake Inhibitor | 20-40 |
Do's
- If the patient has any suicidal ideation, the physician should ask if he/she has any plan to execute it or if he/she has any previous attempts. If they have any specific plan, admit the patient.
- If any patient tells they want to hurt someone, the physician should inform that person as well as to police authority.
- Be empathetic to the patient and listen to them.
- Motivate them to continue the treatment long term and help them with medication adherence.
Don'ts
References
- ↑ NJC Andreasen (1972), "The role of religion in depression", Journal of Religion and Health, Springer
- ↑ Manev R, Manev H (2004). "5-Lipoxygenase as a putative link between cardiovascular and psychiatric disorders". Crit Rev Neurobiol. 16 (1–2): 181–6. doi:10.1615/critrevneurobiol.v16.i12.190. PMID 15581413.
- ↑ Alian S, Masoudzadeh A, Khoddad T, Dadashian A, Ali Mohammadpour R (2013). "Depression in hepatitis B and C, and its correlation with hepatitis drugs consumption (interfron/lamivodin/ribaverin)". Iran J Psychiatry Behav Sci. 7 (1): 24–9. PMC 3939977. PMID 24644496.
- ↑ Senior, Kathryn (1999). "Anecdotal link between mononucleosis and depression disproved". The Lancet. 353 (9148): 214. doi:10.1016/S0140-6736(05)77225-1. ISSN 0140-6736.
- ↑ White PD, Lewis SW (July 1987). "Delusional depression after infectious mononucleosis". Br Med J (Clin Res Ed). 295 (6590): 97–8. doi:10.1136/bmj.295.6590.97-a. PMC 1246972. PMID 3113655.
- ↑ Dayan CM, Panicker V (September 2013). "Hypothyroidism and depression". Eur Thyroid J. 2 (3): 168–79. doi:10.1159/000353777. PMC 4017747. PMID 24847450.
- ↑ Jehan S, Auguste E, Pandi-Perumal SR, Kalinowski J, Myers AK, Zizi F, Rajanna MG, Jean-Louis G, McFarlane SI (2017). "Depression, Obstructive Sleep Apnea and Psychosocial Health". Sleep Med Disord. 1 (3). PMC 5836734. PMID 29517078.
- ↑ Ledochowski M, Sperner-Unterweger B, Widner B, Fuchs D (June 1998). "Fructose malabsorption is associated with early signs of mental depression". Eur. J. Med. Res. 3 (6): 295–8. PMID 9620891.
- ↑ Marsh L (December 2013). "Depression and Parkinson's disease: current knowledge". Curr Neurol Neurosci Rep. 13 (12): 409. doi:10.1007/s11910-013-0409-5. PMC 4878671. PMID 24190780.
- ↑ Siegert RJ, Abernethy DA (April 2005). "Depression in multiple sclerosis: a review". J. Neurol. Neurosurg. Psychiatry. 76 (4): 469–75. doi:10.1136/jnnp.2004.054635. PMC 1739575. PMID 15774430.
- ↑ Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø (November 2016). "Association of Hormonal Contraception With Depression". JAMA Psychiatry. 73 (11): 1154–1162. doi:10.1001/jamapsychiatry.2016.2387. PMID 27680324.
- ↑ Abdel-Motleb M (October 2012). "The neuropsychiatric aspect of Addison's disease: a case report". Innov Clin Neurosci. 9 (10): 34–6. PMC 3508960. PMID 23198275.
- ↑ Paolucci S (February 2008). "Epidemiology and treatment of post-stroke depression". Neuropsychiatr Dis Treat. 4 (1): 145–54. doi:10.2147/ndt.s2017. PMC 2515899. PMID 18728805.
- ↑ Knouse LE, Zvorsky I, Safren SA (December 2013). "Depression in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD): The Mediating Role of Cognitive-Behavioral Factors". Cognit Ther Res. 37 (6): 1220–1232. doi:10.1007/s10608-013-9569-5. PMC 4469239. PMID 26089578.
- ↑ Rao TS, Asha MR, Ramesh BN, Rao KS (April 2008). "Understanding nutrition, depression and mental illnesses". Indian J Psychiatry. 50 (2): 77–82. doi:10.4103/0019-5545.42391. PMC 2738337. PMID 19742217.
- ↑ 16.0 16.1 16.2 Gautam S, Jain A, Gautam M, Vahia VN, Grover S (January 2017). "Clinical Practice Guidelines for the management of Depression". Indian J Psychiatry. 59 (Suppl 1): S34–S50. doi:10.4103/0019-5545.196973. PMC 5310101. PMID 28216784.
- ↑ Kroenke K, Spitzer RL, Williams JB (September 2001). "The PHQ-9: validity of a brief depression severity measure". J Gen Intern Med. 16 (9): 606–13. doi:10.1046/j.1525-1497.2001.016009606.x. PMC 1495268. PMID 11556941.
- ↑ "The Mental Status Examination - Clinical Methods - NCBI Bookshelf".